TABLE 1.
Demographic Data and CT‐Based Body Metrics of Patients with Cirrhotic Liver Disease and the Biliary Atresia Subgroup
| Demographics and Metrics | Patients With Cirrhosis (Group A) | Patients With Biliary Atresia (Group B) |
|---|---|---|
| Age at CT, years | 0.50 (5.3) | 0.39 (0.2) |
| Number | 101 | 69 |
| Sex, male:female | 42:59 | 22:47 |
| tPMSA, cm2 | 3.4 (2.7) | 3.2 (0.9) |
| PMI, cm2/m2 | 5.9 (2.9) | 6.7 (2.5) |
| CSMA, cm2 | 25.9 (25.9) | 24.10 (5.6) |
| SMI, cm2/m2 | 48.0 (16.6) | 51.4 (12.2) |
| Subcutaneous fat area, cm2 | 17.7 (13.7) | 15.9 (11.1) |
| ScFI, cm2/m2 | 31.4 (22.5) | 35.0 (22.9) |
| MELD | 19 (7) | 18.5 (7) |
| MELD subgroups (<15, 15‐20, >20, missing) | 23, 39, 25, 4 | 13, 34, 21, 1 |
| PELD | 10 (9.8) | 10 (9.5) |
| Bilirubin, μmol/L | 146 (181.5) | 141.5 (129.5) |
| International normalized ratio | 1.3 (0.4) | 1.3 (0.4) |
| Albumin, g/L | 34 (8) | 34 (6) |
| Creatinine, μmol/L | 18 (12.8) | 16 (7) |
| Growth failure* | 23/87 (26.4) | 17/60 (28.3) |
| Body mass index | 16.1 (3.4) | 17.6 (3.2) |
| LDLT | 52 | 43 |
| DDLT | 49 | 26 |
| Full size | 21 | 8 |
| Split liver | 80 | 61 |
Data are presented as n, n/all (%), or median (IQR).
*
Missing data not included.